These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 26086074

  • 1. CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells.
    Barrantes-Freer A, Renovanz M, Eich M, Braukmann A, Sprang B, Spirin P, Pardo LA, Giese A, Kim EL.
    PLoS One; 2015; 10(6):e0130519. PubMed ID: 26086074
    [Abstract] [Full Text] [Related]

  • 2. Insight into the complex regulation of CD133 in glioma.
    Campos B, Herold-Mende CC.
    Int J Cancer; 2011 Feb 01; 128(3):501-10. PubMed ID: 20853315
    [Abstract] [Full Text] [Related]

  • 3. The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation.
    Kemper K, Sprick MR, de Bree M, Scopelliti A, Vermeulen L, Hoek M, Zeilstra J, Pals ST, Mehmet H, Stassi G, Medema JP.
    Cancer Res; 2010 Jan 15; 70(2):719-29. PubMed ID: 20068153
    [Abstract] [Full Text] [Related]

  • 4. CD133 glycosylation is enhanced by hypoxia in cultured glioma stem cells.
    Lehnus KS, Donovan LK, Huang X, Zhao N, Warr TJ, Pilkington GJ, An Q.
    Int J Oncol; 2013 Mar 15; 42(3):1011-7. PubMed ID: 23340741
    [Abstract] [Full Text] [Related]

  • 5. RNA aptamers targeting cancer stem cell marker CD133.
    Shigdar S, Qiao L, Zhou SF, Xiang D, Wang T, Li Y, Lim LY, Kong L, Li L, Duan W.
    Cancer Lett; 2013 Mar 01; 330(1):84-95. PubMed ID: 23196060
    [Abstract] [Full Text] [Related]

  • 6. Glioblastoma cells negative for the anti-CD133 antibody AC133 express a truncated variant of the CD133 protein.
    Osmond TL, Broadley KW, McConnell MJ.
    Int J Mol Med; 2010 Jun 01; 25(6):883-8. PubMed ID: 20428792
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. CD133 is a marker of bioenergetic stress in human glioma.
    Griguer CE, Oliva CR, Gobin E, Marcorelles P, Benos DJ, Lancaster JR, Gillespie GY.
    PLoS One; 2008 Jun 01; 3(11):e3655. PubMed ID: 18985161
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis.
    Wu B, Sun C, Feng F, Ge M, Xia L.
    J Exp Clin Cancer Res; 2015 May 14; 34(1):44. PubMed ID: 25967234
    [Abstract] [Full Text] [Related]

  • 11. Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer.
    Florek M, Haase M, Marzesco AM, Freund D, Ehninger G, Huttner WB, Corbeil D.
    Cell Tissue Res; 2005 Jan 14; 319(1):15-26. PubMed ID: 15558321
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. CD133 as a marker for regulation and potential for targeted therapies in glioblastoma multiforme.
    Choy W, Nagasawa DT, Trang A, Thill K, Spasic M, Yang I.
    Neurosurg Clin N Am; 2012 Jul 14; 23(3):391-405. PubMed ID: 22748652
    [Abstract] [Full Text] [Related]

  • 18. Limits of CD133 as a marker of glioma self-renewing cells.
    Clément V, Dutoit V, Marino D, Dietrich PY, Radovanovic I.
    Int J Cancer; 2009 Jul 01; 125(1):244-8. PubMed ID: 19350631
    [Abstract] [Full Text] [Related]

  • 19. Epigenetic regulation of CD133/PROM1 expression in glioma stem cells by Sp1/myc and promoter methylation.
    Gopisetty G, Xu J, Sampath D, Colman H, Puduvalli VK.
    Oncogene; 2013 Jun 27; 32(26):3119-29. PubMed ID: 22945648
    [Abstract] [Full Text] [Related]

  • 20. CD133 is essential for glioblastoma stem cell maintenance.
    Brescia P, Ortensi B, Fornasari L, Levi D, Broggi G, Pelicci G.
    Stem Cells; 2013 May 27; 31(5):857-69. PubMed ID: 23307586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.